Pith. sign in

REVIEW

Recurrent Neural Network-based Model Predictive Control for Continuous Pharmaceutical Manufacturing

Not yet reviewed by Pith; the record is open.

This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.

SPECIMEN: schema-true, not a live event

T0 review · schema-true

One-sentence machine reading of the paper's core claim.

pith:XXXXXXXX · record.json · timestamp

arxiv 1807.09556 v1 pith:W5PZJW4Y submitted 2018-07-25 cs.SY cs.SY

Recurrent Neural Network-based Model Predictive Control for Continuous Pharmaceutical Manufacturing

classification cs.SY cs.SY
keywords continuousmanufacturingmodelpharmaceuticalcontrolespeciallyindustryneural
verification ladder T0 review T1 audit T2 compute T3 formal T4 reserved
0 comments
read the original abstract

The pharmaceutical industry has witnessed exponential growth in transforming operations towards continuous manufacturing to effectively achieve increased profitability, reduced waste, and extended product range. Model Predictive Control (MPC) can be applied for enabling this vision, in providing superior regulation of critical quality attributes. For MPC, obtaining a workable model is of fundamental importance, especially in the presence of complex reaction kinetics and process dynamics. Whilst physics-based models are desirable, it is not always practical to obtain one effective and fit-for-purpose model. Instead, within industry, data-driven system-identification approaches have been found to be useful and widely deployed in MPC solutions. In this work, we demonstrated the applicability of Recurrent Neural Networks (RNNs) for MPC applications in continuous pharmaceutical manufacturing. We have shown that RNNs are especially well-suited for modeling dynamical systems due to their mathematical structure and satisfactory closed-loop control performance can be yielded for MPC in continuous pharmaceutical manufacturing.

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.